SCHEMBL4172204

SCHEMBL4172204

COC(=O)c1ccc(C(=NN)c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.68
RAB9A P51151 6/20 0.59
MAPT P10636 5/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
CASP3 P42574 1/20 0.59
SENP8 Q96LD8 1/20 0.59
SENP7 Q9BQF6 1/20 0.59
SENP6 Q9GZR1 1/20 0.59
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 4/20 0.51
CA1 P00915 4/20 0.51
CA2 P00918 4/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
PTPN1 P18031 1/20 0.51
AGTR1 P30556 1/20 0.51
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Benzoate SCHEMBL28249321 0.84 TSHR (0.95) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL27236438 0.84 TSHR (0.95) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL27839065 0.82 TSHR (0.91) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL29105567 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL28945661 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL29831725 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL1332323 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL1867855 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL28537345 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL7200 0.82 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071782-B2 Synthesis of 1,3,4-trisubstituted and 1,3,4,5-tetrasubstituted pyrazoles JANSSEN PHARMACEUTICA NV (BE) 2011-12-06 US disclosed
US-20090093637-A1 Synthesis of 1,3,4-Trisubstituted and 1,3,4,5-Tetrasubstituted Pyrazoles JANSSEN PHARMACEUTICA NV (BE) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093637-A1 Synthesis of 1,3,4-Trisubstituted and 1,3,4,5-Tetrasubstituted Pyrazoles CYP3A4, CYP4B1, CYP2E1 TSHR 2998/4885RAB9A 3741/4885MAPT 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.